A two stage conditional power adaptive design adjusting for treatment by covariate interaction

Area of Science:

• Clinical Trials Methodology
• Biostatistics
• Translational Medicine

Background:

• Clinical trial designs often assume no covariate by treatment interaction, potentially leading to underpowered studies.
• This assumption can result in inaccurate interpretations of treatment effects and missed opportunities for personalized medicine.

Purpose of the Study:

• To propose a novel two-stage adaptive design for clinical trials that explicitly accounts for potential covariate by treatment interactions.
• To enhance the ability of clinical trials to detect treatment effect modifications by covariates.
• To improve the accuracy of treatment effect interpretation in the presence of interactions.

Main Methods:

• A two-stage adaptive design is proposed, where stage 1 assesses for covariate by treatment interaction.
• A conditional power approach is utilized to manage type I error rates and maintain statistical power.
• The design's statistical properties are evaluated using a binary outcome and various interaction types and allocation schemes.

Main Results:

• The proposed adaptive design demonstrates improved power to detect covariate by treatment interactions compared to traditional designs.
• The conditional power approach effectively controls the overall type I error rate.
• The design facilitates a more nuanced understanding of treatment effects across different patient subgroups.

Conclusions:

• The two-stage adaptive design offers a robust framework for clinical trials where covariate by treatment interactions are anticipated.
• Incorporating interaction testing early in trial design leads to more precise and reliable treatment effect estimates.
• This methodology supports more informed decision-making in drug development and clinical practice.